Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients
Clinical trial NCT04981912 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04981912
- Sponsor
- University of California, San Diego
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2025-07-22
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.